SR

Sujata Rajendrakumar Rathi

Active Director Director DIN 11366651
DIN 11366651 First appointment Nov 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Sujata Rajendrakumar Rathi

Data last updated:

Sujata Rajendrakumar Rathi is a Director at Ultroz Biotech Private Limited (since 2025). The company operates in Healthcare.

DIN 11366651
Primary Designation Director
Industry Healthcare
First Appointment 06 Nov 2025
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ultroz Biotech Private Limited U33119PN2022PTC215964
Director06 Nov 20252022Active

Directorship timeline

Open interactive timeline →
Ultroz Biotech Private Limited
Premium access

Shareholding and investment profile for Sujata Rajendrakumar Rathi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sujata Rajendrakumar Rathi

Sujata Rajendrakumar Rathi currently holds 1 directorship: Ultroz Biotech Private Limited (Director, since 06 Nov 2025).

Sujata Rajendrakumar Rathi was first appointed on 06 Nov 2025 as Director at Ultroz Biotech Private Limited.

The current boards of Sujata Rajendrakumar Rathi's companies include Jyoti Rajat Rathi (Ultroz Biotech Private Limited), Rajat Rajendrakumar Rathi (Ultroz Biotech Private Limited), Rajendrakumar Laxminarayan Rathi (Ultroz Biotech Private Limited), Srushti Rushikesh Rathi (Ultroz Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available